Metanephrines-corrected adrenal vein sampling in primary aldosteronism concurrent with autonomous cortisol secretion.

J Endocrinol Invest

Department of Endocrinology, Sichuan-Chongqing Joint Key Laboratory of Metabolic Vascular Diseases, Chongqing Key Laboratory of Translational Medicine in Major Metabolic Diseases, The First Affiliated Hospital of Chongqing Medical University, No. 1 Youyi Street, Chongqing, 400016, China. 443068494@q

Published: August 2025


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Purpose: Whether metanephrines (MNs)-corrected indices in adrenal venous sampling (AVS) would be useful in subtyping primary aldosteronism (PA) concurrent with autonomous cortisol secretion (ACS) remains unclear.

Methods: This retrospective study included PA patients concurrent with (PA/ACS) or without (isolated PA) ACS who underwent AVS. Firstly, optimal cut-offs for the metanephrine-based selectivity index (SI) and normetanephrine-based SI (SI) were determined using cortisol-corrected SI (SI≥2) as the reference in the isolated PA group. Subsequently, the accuracy of MNs-corrected indices was evaluated in the PA/ACS group.

Results: 130 isolated PA patients and 65 PA/ACS patients were included. In isolated PA, the optimal cut-off values of SI and SI were 3.4 and 1.6, respectively. Eleven PA/ACS patients had unsuccessful cannulation (SI<2), of whom, the diagnoses of 8 and 6 patients were rescued by SI and SI, respectively. Using lateralization index (LI) ≥ 4 to diagnose unilateral PA, 28 out of 65 PA/ACS were identified by cortisol- or NMN-corrected indices, and five more patients were identified by MN-corrected indices. Among 25 PA/ACS patients with a final subtyping diagnosis based on post-surgery outcomes, 52.0% (13/25) were correctly identified by both cortisol- and MNs-corrected indices. In the remaining 12 patients, four were correctly identified by MNs-corrected indices, one was correctly identified by cortisol-corrected indices alone, two were judged as unsuccessful cannulation by SI and all three indicators were wrongly subtyped in the five patients.

Conclusion: For patients with PA/ACS, MN-corrected AVS serves as a complementary approach to cortisol-corrected AVS.

Download full-text PDF

Source
http://dx.doi.org/10.1007/s40618-025-02660-yDOI Listing

Publication Analysis

Top Keywords

primary aldosteronism
8
aldosteronism concurrent
8
concurrent autonomous
8
autonomous cortisol
8
cortisol secretion
8
mns-corrected indices
8
pa/acs patients
8
metanephrines-corrected adrenal
4
adrenal vein
4
vein sampling
4

Similar Publications

Aldosterone is synthesized by the CYP11B2 enzyme, primarily in the zona glomerulosa of the adrenal gland. It exerts its classical effects on sodium and water balance in the renal distal nephron through binding to the mineralocorticoid receptor (MR). Excess aldosterone production or overactivation of the MR outside the distal nephron leads to cardiac, renal, and vascular injury by increasing oxidative stress and activating the inflammatory and fibrotic pathways.

View Article and Find Full Text PDF

[Paraneoplastic rhabdomyolysis].

Inn Med (Heidelb)

September 2025

Klinik für Allgemeine Innere Medizin und Altersmedizin, Evangelisches Klinikum Köln Weyertal, Weyertal 76, 50931, Köln, Deutschland.

A 49-year-old female patient presented with decline of general health and muscle pain. Laboratory findings showed a combination of rhabdomyolysis and severe hypokalemia. Symptoms improved with potassium supplementation.

View Article and Find Full Text PDF

Context: Although salivary steroid sampling offers several advantages, the diagnostic potential of salivary steroid metabolites remains largely unexplored.Objective To evaluate the diagnostic utility of salivary steroid profiling in patients with adrenal diseases.

Design: Prospective multicenter study.

View Article and Find Full Text PDF

Primary Aldosteronism: Ubiquitous, Yet Unrecognized.

J Am Coll Cardiol

August 2025

Center for Adrenal Disorders, Division of Endocrinology, Diabetes, and Hypertension, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA. Electronic address:

View Article and Find Full Text PDF

Rethinking Primary Aldosteronism: The 2025 John H. Laragh Research Award.

Am J Hypertens

September 2025

Department of Medicine, Division of Endocrinology and Metabolism, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.

Dr John Laragh, a pioneer in the field of hypertension, held a fundamental belief in the need to challenge existing dogmas in medicine to enhance our scientific understanding of disease and advance patient care. Perhaps in no area of hypertension does this ring truer with than primary aldosteronism (PA). Following its initial description in the mid-1950s with an initial surge in diagnoses soon thereafter, PA was ultimately relegated to be considered a "zebra" of hypertension felt to be responsible for only a small percentage of cases.

View Article and Find Full Text PDF